Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 8, 2025
Ainnocence Unveils Core Challenges Undermining AI-Driven Small-Molecule Drug Discovery
EIN Presswire
·
May 8, 2025
How current methodologies fail to address critical challenges in early stage drug discovery. SAN FRANCISCO, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Ainnocence, a leader in next-generation AI drug-discovery solutions, today released a …
SplashBI Supercharges Executive Team with CFO & CAIO Appointments to Power the Future of Enterprise Analytics
EIN Presswire
·
May 8, 2025
DULUTH, GA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- SplashBI, the AI-powered analytics platform delivering conversational insights, unified reporting, and advanced analytics, today announced two high-impact additions to its executive team. Dan …
Superior Sensor Technology Expands CP Series with Advanced Dual Pressure Sensors Featuring Integrated Snore Detection
EIN Presswire
·
May 8, 2025
New CP203 and CP303 Enhance Sleep Apnea Therapy with Built-In Snore Detection, Improving Patient Outcomes and Device Performance LOS GATOS, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Superior Sensor Technology today announced the expansion of …
Cloudforce and Microsoft Support the Launch of TerpAI at UMD’s Bitcamp 2025, Advancing AI Innovation in Higher Ed
EIN Presswire
·
May 8, 2025
NATIONAL HARBOR, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Innovation took center stage at the University of Maryland’s (UMD) 11th annual Bitcamp hackathon, the largest collegiate hackathon on the East Coast, where more than 1,000 students …
Karger Publishers Launches AI Innovation Hub to Drive Advancement in Global Health
EIN Presswire
·
May 8, 2025
The AI Innovation Hub is for innovators, researchers …
Display Week 2025: SunLED to Demo Near-Infrared Technology that Brings the Benefits of Natural Sunlight Indoors
EIN Presswire
·
May 8, 2025
The technology can be integrated into screens to deliver the essential part of sunlight absent in indoor light to users while they work, improving well-being SAN JOSE, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- SunLED Life Science, a health- …
Arteriovenous Malformations Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, Trends
EIN Presswire
·
May 8, 2025
The Business Research Company's Arteriovenous Malformations Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, Trends LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2025 /EINPresswire.com/ -- The Business Research Company’ …
Business Awards UK 2025 Care Awards: The Organisations Putting People First in UK Care
EIN Presswire
·
May 8, 2025
DONCASTER, UNITED KINGDOM, May 8, 2025 /EINPresswire.com/ -- Business Awards UK is proud to announce the Winners and Finalists of the 2025 Care Awards, recognising standout achievements across the UK’s care sector. This year’s awards highlight the …
Raya Therapeutic Appoints Juan Carlos Gomez MD, MBA, Chief Medical Officer of Shionogi and Company to its Board
EIN Presswire
·
May 8, 2025
Dr. Gomez brings extensive neuroscience and orphan disease development experience to Raya as it plans multiple clinical trials in 2026. MONTREAL, QUEBEC, CANADA, May 8, 2025 /EINPresswire.com/ -- Raya Therapeutic Inc., (“Raya”) a mission-driven company …
UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum
EIN Presswire
·
May 8, 2025
AI will accelerate discovery, but the breakthrough is off‑the‑shelf vaccines targeting shared Dark‑Genome drivers—paired with nextgen immunotherapy combinations PALO ALTO AND SAN JOSE, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- At SynBioBeta, …
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, …
Nova Leap Health Corp. Posts Q1 2025 Results
GlobeNewswire
·
May 8, 2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is …
VitalHub Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Annual Recurring Revenue (ARR)⁽¹⁾ up 54% YoY to $73.7 million Total Revenue up 42% YoY to $21.7 million Adjusted EBITDA⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire
·
May 8, 2025
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 8, 2025
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
GlobeNewswire
·
May 8, 2025
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate …
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
GlobeNewswire
·
May 8, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …
Galecto Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
GlobeNewswire
·
May 8, 2025
MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …